Barclays Capital downgrades ACADIA Pharmaceuticals (Nasdaq: ACAD) from Overweight to Equal Weight.

Shares of ACADIA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE